Hematologist and Clinical Investigator

Hematologist and Clinical Investigator Opportunity
Tennessee Oncology
Physician
Hematology
Clinic Location: Employment: Full-Time
Unique opportunity to blend clinical and research responsibilities
Hematologist and Clinical Investigator in the Multiple Myeloma Research Program at the Greco-Hainsworth Centers for Research at Tennessee Oncology
Private Practice, Outpatient/Inpatient
Young to mid-career clinical researcher with a strong background in providing direct patient care and conducting clinical research in plasma cell disorders
Will treat malignant hematology cases both outpatient/inpatient
Benefit from highly competitive compensation structures. Professional Growth: CME reimbursement
Medical, Dental, Vision, Short-Term and Long-Term Disability, Life, and Accidental Death.
Secure Future: Robust retirement savings plan.
Future Stability: Partnership opportunity offered.
Community Care: Make a real difference by caring for patients in their local communities.
Opportunity to PI Phase 1-Phase 4 clinical trials in MM, including cellular therapy trials.
Innovative Research: Enroll patients in cutting-edge clinical trials.
Academic Excellence: Present and participate in research at prestigious conferences.
Supportive Environment: Join a physician-led and managed organization that values clinical autonomy, work-life balance, and quality patient care while prioritizing your professional development and well-being.
We are seeking a BC/BE Hematologist Oncologist with an interest in hematologic malignancies/cellular therapy to join a growing program in Middle Tennessee.
The successful candidate will be a fellowship-trained Hematologist Oncologist with experience in caring for patients with hematologic malignancies including the evaluation and treatment of cellular therapy recipients. Clinically this individual will join five Nashville-based physicians in caring for patients with hematologic malignancies. The ideal candidate is a young to mid-career clinical researcher concentrating in plasma cell disorders who will join and further develop a robust clinical trial program for patients with MM through the Greco-Hainsworth Centers for Research.
Our program is affiliated with a committed, national hospital system who is a regional leader in several specialties and has prioritized cancer care as an important component of its strategic vision. The inpatient service is supported by a dedicated group of advanced practice providers (APPs) who provide 24/7/365 coverage.
Total Group Count: 105 Physicians and 105 APPs
Phase 1, 2, and 3 clinical trials
Ancillary services include: in-house lab, in-house pathology, infusion centers, genetic counseling, proton therapy, imaging, retail pharmacy, nutritionist, physical therapist, social workers, chaplain
Medical services include: hematology/medical oncology, radiation oncology, palliative care, and APPs
Tennessee Oncology is built on a foundation of clinical excellence, compassionate support, and commitment to helping our patients through exceedingly challenging times in their lives. The education and experience of our physicians and healthcare team enable us to provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their homes. The practice offers Hematology/Medical Oncology, Radiation Oncology, Palliative Care, and Clinical trial & Research Programs through the Greco-Hainsworth Centers for Research at Tennessee Oncology .
Tennessee Oncology is a proud partner of OneOncology . OneOncology is a national partnership of leading independent community oncology practices working together to improve the lives of everyone living with cancer with a physician-led, data-driven, technology-powered, and patient-centric model. Through OneOncology, partner practices have shared technology platforms that foster communication, data sharing, and clinical excellence across the network. OneOncology’s non-exclusive clinical trial site management subsidiary, OneR, delivers complex, multi-center clinical trials to affiliated practices.